Home
HRMY
HRMY News

Latest Harmony Biosciences Holdings Inc. (HRMY) News on January 20, 2025

Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge

Zacks

5 days ago

Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge

How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48%

Zacks

5 days ago

How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48%

Harmony Biosciences price target raised to $32 from $31 at BofA

TipRanks

5 days ago

Harmony Biosciences price target raised to $32 from $31 at BofA

Argus Research

6 days ago

HRMY: Raising target price to $38.00

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Zacks

6 days ago

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Are Investors Undervaluing Genmab (GMAB) Right Now?

Zacks

6 days ago

Are Investors Undervaluing Genmab (GMAB) Right Now?

Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential

Insider Monkey

7 days ago

Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

Investor's Business Daily

7 days ago

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

MT Newswires

7 days ago

Harmony Biosciences Reports Preliminary Q4, 2024 Net Product Revenue; 2025 Revenue Guidance Issued

Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Business Wire

7 days ago

Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Argus Research

a month ago

HRMY: Raising target price to $37.00

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

PR Newswire

a month ago

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Argus Research

a month ago

HRMY: Raising target price to $35.00

MT Newswires

a month ago

HC Wainwright Initiates Harmony Biosciences at Buy With $75 Price Target

Argus Research

a month ago

HRMY: Lowering target price to $34.00

Argus Research

2 months ago

HRMY: Lowering target price to $36.00

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT

PR Newswire

2 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT

Argus Research

2 months ago

HRMY: Raising target price to $37.00

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

PR Newswire

2 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Argus Research

2 months ago

HRMY: Rating increased to a BUY

Argus Research

2 months ago

HRMY: Lowering target price to $35.00

There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings

Simply Wall St.

2 months ago

There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings

Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.

3 months ago

Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Zacks

3 months ago

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

HRMY vs. REGN: Which Stock Is the Better Value Option?

Zacks

3 months ago

HRMY vs. REGN: Which Stock Is the Better Value Option?

Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

PR Newswire

3 months ago

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

MT Newswires

3 months ago

Harmony Biosciences Holdings Launches Secondary Common Stock Offering

Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com

3 months ago

Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Harmony Biosciences Holdings Inc Earnings Call

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

PR Newswire

3 months ago

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat

Investor's Business Daily

3 months ago

Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat

Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript

Motley Fool

3 months ago

Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates

Zacks

3 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates

MT Newswires

3 months ago

Harmony Biosciences Holdings Q3 Adjusted Earnings, Net Product Revenue Increase

HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS

PR Newswire

3 months ago

HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?

Zacks

3 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?

HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024

PR Newswire

3 months ago

HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024

Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth

Insider Monkey

3 months ago

Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Insider Monkey

3 months ago

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com

3 months ago

Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...

Argus Research

3 months ago

HRMY: Lowering target price to $36.00

Investing.com

4 months ago

Mizuho adds 2 new stocks to its Top Picks list

HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY

PR Newswire

4 months ago

HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY

Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?

Insider Monkey

4 months ago

Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?

Zacks

4 months ago

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?

HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024

PR Newswire

4 months ago

HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024

Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?

Zacks

4 months ago

Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?

Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know

Zacks

4 months ago

Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know

HRMY vs. REGN: Which Stock Should Value Investors Buy Now?

Zacks

4 months ago

HRMY vs. REGN: Which Stock Should Value Investors Buy Now?

Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish

Insider Monkey

4 months ago

Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says

Benzinga

4 months ago

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says

MT Newswires

4 months ago

Harmony Biosciences Boosted by Narcolepsy Treatment, Diversification Outlook. UBS Says

MT Newswires

4 months ago

UBS Initiates Harmony Biosciences Holdings at Buy With $56 Price Target

Argus Research

5 months ago

HRMY: Lowering target price to $37.00

HRMY or REGN: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

HRMY or REGN: Which Is the Better Value Stock Right Now?

Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?

Zacks

5 months ago

Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

PR Newswire

5 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Argus Research

5 months ago

HRMY: Raising target price to $38.00

Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock

Zacks

5 months ago

Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock

Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?

Zacks

5 months ago

Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?

HRMY vs. REGN: Which Stock Is the Better Value Option?

Zacks

5 months ago

HRMY vs. REGN: Which Stock Is the Better Value Option?

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Zacks

5 months ago

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Harmony Biosciences Holdings Second Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

5 months ago

Harmony Biosciences Holdings Second Quarter 2024 Earnings: EPS Beats Expectations

MT Newswires

5 months ago

Mizuho Securities Adjusts Harmony Biosciences Price Target to $42 From $40, Maintains Outperform Rating

Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript

Motley Fool

5 months ago

Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript

MT Newswires

5 months ago

Harmony Biosciences' Q2 Adjusted EPS, Revenue Rise; Shares Gain

Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates

Zacks

5 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates

Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028

GlobeNewswire

5 months ago

Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028

Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

6 months ago

Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Is Going Strong: Is the Market Following Fundamentals?

Argus Research

6 months ago

HRMY: Lowering target price to $35.00

HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024

PR Newswire

6 months ago

HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024

HRMY or REGN: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

HRMY or REGN: Which Is the Better Value Stock Right Now?

Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?

Zacks

6 months ago

Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Zacks

6 months ago

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Argus Research

6 months ago

HRMY: What does Argus have to say about HRMY?

MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?

Zacks

6 months ago

MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?

Argus Research

6 months ago

HRMY: Raising target price to $36.00

5 High Earnings Yield Value Stocks That You Shouldn't Ignore

Zacks

6 months ago

5 High Earnings Yield Value Stocks That You Shouldn't Ignore

HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)

PR Newswire

7 months ago

HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)

MT Newswires

7 months ago

Harmony Biosciences Says FDA Approves Supplemental NDA for Pediatric Narcolepsy Treatment

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX® (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY

PR Newswire

7 months ago

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX® (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY

MT Newswires

7 months ago

Citigroup Initiates Harmony Biosciences at Buy Rating With $48 Price Target

Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?

Zacks

7 months ago

Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?

HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1

PR Newswire

7 months ago

HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1

HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE

PR Newswire

8 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Simply Wall St.

9 months ago

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

9 months ago

Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice

Zacks

9 months ago

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice

HRMY or TECH: Which Is the Better Value Stock Right Now?

Zacks

9 months ago

HRMY or TECH: Which Is the Better Value Stock Right Now?

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript

Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript

Motley Fool

9 months ago

Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript

Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View

Benzinga

9 months ago

Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View

MT Newswires

9 months ago

Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise

Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024

GuruFocus.com

9 months ago

Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

GlobeNewswire

9 months ago

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets

PR Newswire

9 months ago

Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets

Argus Research

9 months ago

HRMY: Lowering target price to $30.00

Share on Social Networks: